ImmuSmol develops small molecule antibodies for research, diagnostics, and therapy.
Business Model:
Revenue: $325.3k
Employees: 11-50
Address:
City: Bordeaux
State: Aquitaine
Zip:
Country: France
ImmuSmol sells validated primary antibodies, for small molecule detection and visualization in cells and tissues. Their R and D activities also involve a network of scientific consultants and collaborators, bringing their insights into areas such as chemistry, immunology, oncology, and neuroscience.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|